Rapport Therapeutics Inc (RAPP) Implied Volatility Current

Tracking RAPP implied volatility helps you identify when options premiums on Rapport Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Rapport Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when RAPP IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Rapport Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For RAPP, tracking metrics like RAPP IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on RAPP signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders.

The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is based in Boston, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where RAPP implied volatility sits today versus where it has been. Our scanner ranks Rapport Therapeutics Inc implied volatility against its historical range, surfaces extremes in RAPP IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Rapport Therapeutics Inc IV is rich or cheap — measure it, then act on it.